SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Cogent Biosciences signs commercial supply agreement with Hovione for bezuclastinib

Cogent Biosciences entered a Commercial Supply Agreement with Hovione to manufacture bezuclastinib spray-dried dispersion and tablets. Deal uses rolling quarterly forecasts with a binding near-term portion and minimum, declining purchase requirements.

COGT

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories